financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Keeps Hold Opinion On Shares Of Prudential Financial Inc.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Keeps Hold Opinion On Shares Of Prudential Financial Inc.
May 2, 2024 5:20 AM

07:55 AM EDT, 05/02/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We keep our 12-month target price of $115, valuing PRU shares at 8.3x our '25 operating EPS estimate of $13.90 and 8.9x our '24 EPS estimate of $12.87 (cut today by $0.33), versus the five-year average forward multiple of 7.8x and a peer average of 8.7x. Q1 operating EPS of $3.12 versus $2.70 lagged our $3.48 EPS estimate, the $3.15 consensus view, as a 45% rise in operating revenues on a 70% surge in insurance premiums, 12% higher investment income, and 8% rise in asset management revenues were offset by 48% higher expenses on a 65% surge in insurance and annuity benefits. The surge in insurance premiums reflects a recovery in the transactional pension risk transfer (PRT) market, as the Retirement Strategies unit posted the strongest PRT Q1 sales in over a decade. We applaud these results, but caution they are not a run rate. We raise our '24 operating revenue growth forecast to a rise of 7% to 12% (from 2% to 5%), but think mixed margin trends remove a catalyst from the shares (currently yielding 4.6%).

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Keeps Hold Opinion On Shares Of Dexcom, Inc.
Research Alert: CFRA Keeps Hold Opinion On Shares Of Dexcom, Inc.
Oct 31, 2025
11:35 AM EDT, 10/31/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We cut our 12-month target to $77 from $89, about 32x our 2026 EPS, below DXCM's average forward P/E and slightly under MedTech peers. We lift our 2025 EPS by...
Research Alert: CFRA Keeps Buy Opinion On Shares Of Edwards Lifesciences Corporation
Research Alert: CFRA Keeps Buy Opinion On Shares Of Edwards Lifesciences Corporation
Oct 31, 2025
11:40 AM EDT, 10/31/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our 12-month target price to $100 from $93, 35x our 2026 EPS and a slight premium to the company's long-term average forward P/E. We lift our 2025 EPS...
Research Alert: CFRA Maintains Hold Opinion On Shares Of Southern Copper Corporation
Research Alert: CFRA Maintains Hold Opinion On Shares Of Southern Copper Corporation
Oct 31, 2025
11:10 AM EDT, 10/31/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We increase our 12-month target price by $55 to $151, driven by an EV/EBITDA multiple of 14.5x applied to our 2027 EBITDA estimate, which is a premium to SCCO's three-year...
Research Alert: CFRA Maintains Sell Opinion On Shares Of Edison International
Research Alert: CFRA Maintains Sell Opinion On Shares Of Edison International
Oct 31, 2025
11:30 AM EDT, 10/31/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Our 12-month target remains $48, 7.8x our 2026 EPS estimate (down $0.05 to $6.08; 2025 estimate remains $6.03), a wide discount to peers based on weaker growth expectations vs. peers...
Copyright 2023-2026 - www.financetom.com All Rights Reserved